MRTX logo

Mirati Therapeutics (MRTX) Net Margin

Annual Net Margin

-5957.44%
-5150.44%-638.22%

December 31, 2022


Summary


Performance

MRTX Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMRTXprofitabilitymetrics:

Quarterly Net Margin

-987.22%
+305.06%+23.61%

September 30, 2023


Summary


Performance

MRTX Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMRTXprofitabilitymetrics:

Net Margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

MRTX Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-638.2%+69.1%
3 y3 years+6.7%-27.9%
5 y5 years--

MRTX Net Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year+638.2%at lowat high+6662.7%
5 y5-year+638.2%+7.1%+785.3%+6662.7%
alltimeall time>+9999.0%+7.1%-1464.9%+6662.7%

Mirati Therapeutics Net Margin History

DateAnnualQuarterly
Sep 2023
-
-987.22%(-23.6%)
Jun 2023
-
-1292.28%(-49.8%)
Mar 2023
-
-2575.50%(-88.1%)
Dec 2022
-5957.44%(+638.2%)
-21.68 K%(+578.3%)
Sep 2022
-
-3195.75%(-2.9%)
Jun 2022
-
-3290.66%(-87.6%)
Mar 2022
-
-26.57 K%(-60.2%)
Dec 2021
-807.00%(-69.8%)
-66.76 K%(>+9900.0%)
Sep 2021
-
-111.51%(-98.1%)
Dec 2020
-2671.57%(-58.1%)
-5951.70%(+671.2%)
Sep 2020
-
-771.73%(-97.6%)
Mar 2020
-
-32.46 K%(+135.9%)
Dec 2019
-6382.19%(+738.2%)
-13.76 K%(+151.0%)
Sep 2019
-
-5482.79%(-30.5%)
Jun 2019
-
-7893.24%(+140.9%)
Mar 2019
-
-3276.05%(+301.3%)
Dec 2018
-761.40%(+142.0%)
-816.33%(+415.3%)
Mar 2018
-
-158.41%(-78.2%)
Dec 2011
-314.59%(-48.7%)
-725.86%(-84.2%)
Sep 2011
-
-4595.51%(+3877.4%)
Jun 2011
-
-115.54%(-5.6%)
Mar 2011
-
-122.45%(-54.8%)
Dec 2010
-613.39%
-270.93%(-67.0%)
Sep 2010
-
-820.10%(+25.4%)
DateAnnualQuarterly
Jun 2010
-
-654.10%(-31.7%)
Mar 2010
-
-957.60%(-7.4%)
Dec 2009
-781.13%(+2483.1%)
-1033.84%(-7.5%)
Sep 2009
-
-1117.53%(-37.3%)
Jun 2009
-
-1782.73%(+385.7%)
Mar 2009
-
-367.03%(-607.4%)
Dec 2008
-30.24%(-78.7%)
72.33%(-226.3%)
Sep 2008
-
-57.29%(-66.7%)
Jun 2008
-
-172.22%(+39.2%)
Mar 2008
-
-123.72%(-17.8%)
Dec 2007
-142.07%(+203.1%)
-150.53%(-1.0%)
Sep 2007
-
-152.09%(-10.5%)
Jun 2007
-
-169.86%(+84.9%)
Mar 2007
-
-91.87%(+26.4%)
Dec 2006
-46.87%(-79.5%)
-72.70%(-306.5%)
Sep 2006
-
35.21%(-122.7%)
Jun 2006
-
-155.15%(-48.3%)
Mar 2006
-
-300.30%(-34.3%)
Dec 2005
-228.63%(+76.1%)
-457.29%(+98.5%)
Sep 2005
-
-230.40%(+28.8%)
Jun 2005
-
-178.84%(+18.7%)
Mar 2005
-
-150.66%
Dec 2004
-129.83%(+137.1%)
-
Dec 2003
-54.75%
-

FAQ

  • What is Mirati Therapeutics annual net profit margin?
  • What is the all time high annual net margin for Mirati Therapeutics?
  • What is Mirati Therapeutics annual net margin year-on-year change?
  • What is Mirati Therapeutics quarterly net profit margin?
  • What is the all time high quarterly net margin for Mirati Therapeutics?
  • What is Mirati Therapeutics quarterly net margin year-on-year change?

What is Mirati Therapeutics annual net profit margin?

The current annual net margin of MRTX is -5957.44%

What is the all time high annual net margin for Mirati Therapeutics?

Mirati Therapeutics all-time high annual net profit margin is -30.24%

What is Mirati Therapeutics annual net margin year-on-year change?

Over the past year, MRTX annual net profit margin has changed by -5150.44% (-638.22%)

What is Mirati Therapeutics quarterly net profit margin?

The current quarterly net margin of MRTX is -987.22%

What is the all time high quarterly net margin for Mirati Therapeutics?

Mirati Therapeutics all-time high quarterly net profit margin is 72.33%

What is Mirati Therapeutics quarterly net margin year-on-year change?

Over the past year, MRTX quarterly net profit margin has changed by +2208.53% (+69.11%)